Search results for "Reso"

showing 10 items of 13841 documents

Metabolite identification in human liver needle biopsies by high-resolution magic angle spinning1H NMR spectroscopy

2006

High-resolution magic angle spinning (HR-MAS) 1 H NMR spectroscopy of intact human liver needle biopsies has not been previously reported. HR-MAS NMR spectra collected on 17 specimens with tissue amounts between � 0.5 and 12 mg showed very good spectral resolution and signal-to-noise ratios. One-dimensional 1 H spectra revealed many intense signals corresponding to cellular metabolites. In addition, some high molecular weight metabolites, such as glycogen and mobile fatty acids, could be observed in some spectra. Resonance assignments for 22 metabolites were obtained by combining the analysis of three different types of 1D 1 H spectral editing, such as T2 filtering or the nuclear Overhauser…

AdultLiver CirrhosisMaleMagnetic Resonance SpectroscopyMetaboliteNuclear Overhauser effectSensitivity and Specificitychemistry.chemical_compoundNuclear magnetic resonanceMagic angle spinningHumansRadiology Nuclear Medicine and imagingSpectroscopySpectroscopyAgedHepatitis ChronicChemistryBiopsy NeedleReproducibility of ResultsResonanceNuclear magnetic resonance spectroscopyMiddle AgedNMR spectra databaseProton NMRMolecular MedicineFemaleSpin Labelslipids (amino acids peptides and proteins)ProtonsBiomarkersNMR in Biomedicine
researchProduct

Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?

2014

Detection and characterization of focal lesions in the cirrhotic liver may pose a diagnostic dilemma. Several benign and malignant lesions may be found in a cirrhotic liver along with hepatocellular carcinoma (HCC), and may exhibit typical or atypical imaging features. In this pictorial essay, we illustrate computed tomography and magnetic resonance imaging findings of lesions such as simple bile duct cysts, hemangioma, focal nodular hyperplasia-like nodules, peribiliary cysts, intrahepatic cholangiocarcinoma, lymphoma, and metastases, all of which occur in cirrhotic livers with varying prevalences. Pseudolesions, such as perfusion anomalies, focal confluent fibrosis, and segmental hyperpla…

AdultLiver CirrhosisMalePathologymedicine.medical_specialtyCirrhosisCarcinoma HepatocellularLymphomaBile Duct DiseasesHemangiomaCholangiocarcinomaFibrosismedicineCarcinomaPrevalenceHumansRadiology Nuclear Medicine and imagingAbdominal ImagingNeoplasm MetastasisIntrahepatic CholangiocarcinomaAgedFocal liver lesions CT MRImedicine.diagnostic_testbusiness.industryCystsLiver DiseasesLiver NeoplasmsMagnetic resonance imagingHyperplasiaMiddle Agedmedicine.diseaseMagnetic Resonance ImagingBile Ducts IntrahepaticBile Duct NeoplasmsLiverFocal Nodular HyperplasiaHepatocellular carcinomaFemaleRadiologyCardiology and Cardiovascular MedicinebusinessHemangiomaTomography X-Ray Computed
researchProduct

Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies.

2010

Among the different processes occurring during the evolution of liver disease, fibrosis has a predominant role. Liver fibrosis mechanisms are fairly constant irrespective of the underlying etiology. Cirrhosis is the end-stage of this reaction. Metabolic profiles, which are affected by many physiological and pathological processes, may provide further insight into the metabolic consequences of this severe liver disease. The aim of this study was to demonstrate the applicability of 1H high resolution magic angle spinning (HR-MAS) NMR spectroscopy in the biochemical profile determination of human liver needle biopsy samples for the characterization of metabolic alterations related to the sever…

AdultLiver CirrhosisMalePathologymedicine.medical_specialtyCirrhosisMagnetic Resonance SpectroscopyBiopsyBiologyChronic liver diseaseLiver diseaseFibrosisBiopsyGeneticsmedicineMetabolomeHumansAgedmedicine.diagnostic_testLiver DiseasesCancerGeneral MedicineMiddle Agedmedicine.diseaseMolecular medicineLiverChronic DiseaseMetabolomeFemaleInternational journal of molecular medicine
researchProduct

Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia

2018

Background The World Health Organization has set an ambitious goal of eliminating viral hepatitis as a major public health threat by 2030. However, in sub-Saharan Africa, antiviral treatment of chronic hepatitis B (CHB) is virtually unavailable. Herein, we present the 1-year results of a pilot CHB treatment program in Ethiopia. Methods At a public hospital in Addis Ababa, CHB patients were treated with tenofovir disoproxil fumarate based on simplified eligibility criteria. Baseline assessment included liver function tests, viral markers, and transient elastography (Fibroscan). Changes in laboratory markers were analyzed using Wilcoxon signed-rank tests. Adherence to therapy was measured by …

AdultLiver CirrhosisMalemedicine.medical_specialtyAdolescentEpidemiologylcsh:MedicinePilot ProjectsAntiviral therapymedicine.disease_causeAntiviral AgentsYoung Adult03 medical and health sciencesHepatitis B Chronic0302 clinical medicineChronic hepatitisInternal medicineEpidemiologymedicineHumansPilot program030212 general & internal medicineViral hepatitisTenofovirHepatitis B virusmedicine.diagnostic_testbusiness.industryPublic healthlcsh:RGeneral MedicineMiddle AgedViral Loadmedicine.diseaseResource-limited settingsTreatment Adherence and ComplianceTreatment OutcomeFemale030211 gastroenterology & hepatologyEthiopiaTransient elastographybusinessLiver function testsViral hepatitisBiomarkersFollow-Up StudiesResearch ArticleBMC Medicine
researchProduct

Focal lesions in cirrhosis: Not always HCC.

2017

Even though most hepatocellular carcinomas (HCC) develop in the setting of cirrhosis, numerous other focal liver lesions and pseudolesions may be encountered. The role of the radiologist is therefore to differentiate these lesions from HCC to avoid under- and overdiagnosis. There are several ways of classifying these lesions: those which predate the development of fibrosis and cirrhosis (cystic lesions, hemangioma), those related to or a consequence of cirrhosis (regenerative nodules, dysplastic nodules, focal fibrosis, peribiliary cysts, shunts, or even cholangiocarcinoma), and those related to the underlying cause of chronic liver disease (lymphoma). Finally, some may develop independentl…

AdultLiver CirrhosisMalemedicine.medical_specialtyPathologyCirrhosisCarcinoma HepatocellularBile Duct NeoplasmChronic liver disease030218 nuclear medicine & medical imagingHemangiomaCholangiocarcinomaDiagnosis Differential03 medical and health sciences0302 clinical medicineFibrosismedicineHumansRadiology Nuclear Medicine and imagingOverdiagnosisAgedAged 80 and overmedicine.diagnostic_testbusiness.industryCystsLiver NeoplasmsMagnetic resonance imagingGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance Imagingdigestive system diseasesBile Ducts IntrahepaticBile Duct Neoplasms030211 gastroenterology & hepatologyFemaleRadiologyDifferential diagnosisbusinessHemangiomaTomography X-Ray ComputedEuropean journal of radiology
researchProduct

Predictors of mortality in patients under treatment for chronic hepatitis B in Ethiopia: a prospective cohort study

2019

Abstract Background Antiviral treatment for chronic hepatitis B (CHB) is largely unavailable in sub-Saharan Africa; hence, little is known about the prognosis after initiating treatment in African CHB patients. In this study we aimed to assess predictors of mortality in one of the largest CHB cohorts in sub-Saharan Africa. Methods Two-hundred-and-seventy-six CHB patients who started treatment with tenofovir disoproxil fumarate at a public hospital in Ethiopia between March 18, 2015, and August 1, 2017, were included in this analysis. Patients were followed up until October 1, 2017, and deaths were ascertained through hospital records and telephone interview with relatives. Decompensated cir…

AdultLiver CirrhosisMalemedicine.medical_specialtyTime FactorsSurvivalAdolescentEpidemiologyPhysical examinationAntiviral therapyAntiviral AgentsBody Mass Index03 medical and health sciencesYoung Adult0302 clinical medicineHepatitis B ChronicInterquartile rangeRisk FactorsInternal medicineEpidemiologyMedicineHumansProspective Studieslcsh:RC799-869Prospective cohort studyTenofovirProportional Hazards Modelsmedicine.diagnostic_testbusiness.industryHazard ratioGastroenterologyAge FactorsGeneral MedicineHepatitis BHepatologyMiddle Agedmedicine.diseaseHepatitis BResource-limited settingsSurvival RateVDP::Medisinske Fag: 700::Helsefag: 800030220 oncology & carcinogenesislcsh:Diseases of the digestive system. Gastroenterology030211 gastroenterology & hepatologyFemaleEthiopiabusinessBody mass indexResearch Article
researchProduct

Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD)

2019

PurposeTo investigate the performance of MR-based texture analysis (TA) for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).MethodsFifty-four adult patients (33 females, 21 males, mean age 49.813.5years) with biopsy-proven NAFLD were enrolled and underwent MR imaging on a 1.5T system. TA parameters were extracted on axial noncontrast 3D-GRE T1W images (slice thickness=4.6mm) using a commercially available research software (TexRAD). Receiver operating curves (ROC), areas under the ROC (AUROC) and 95% confidence intervals (CI) were calculated to assess the accuracy of each TA parameter for the diagnosis of significant (F2) and advanced fibrosis (F…

AdultLiver CirrhosisMalemedicine.medical_specialtyUrologyGastroenterology030218 nuclear medicine & medical imaging03 medical and health sciencesImaging Three-Dimensional0302 clinical medicineNon-alcoholic Fatty Liver DiseaseFibrosisInternal medicineImage Interpretation Computer-AssistedNonalcoholic fatty liver diseaseHumansNonalcoholic fatty liver diseaseMedicineRadiology Nuclear Medicine and imagingIn patientTexture analysiAgedRetrospective StudiesRank correlationRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryGastroenterologyMagnetic resonance imagingMiddle AgedHepatologymedicine.diseaseMagnetic Resonance ImagingConfidence intervalLiverMagnetic resonance030220 oncology & carcinogenesisElasticity Imaging TechniquesFemaleSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessHepatic fibrosisHepatic fibrosisSoftwareAbdominal Radiology
researchProduct

Analysis of different contrast enhancement patterns after microbubble-based contrast agent injection in liver hemangiomas with atypical appearance on…

2006

BACKGROUND: We describe different possible enhancement patterns in liver hemangiomas with atypical appearance on baseline ultrasound after microbubble-based contrast agent injection. METHODS: From a series of 253 consecutive lesions that were indeterminate on baseline ultrasound and then scanned after injection of air-filled microbubble contrast agent, 65 focal liver lesions were retrospectively selected on the basis of a diagnosis of liver hemangioma on multiphase contrast-enhanced computed tomography (n = 23), magnetic resonance imaging (n = 27), or histology (n = 15). Each lesion was scanned during arterial phase (30 s after microbubble injection) and late phase (5 min after injection). …

AdultLiver CirrhosisMalemedicine.medical_specialtyUrologyLiver CirrhosiContrast MediaLesionAngiomaPolysaccharidesInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingAgedUltrasonographyMicrobubblesRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryLiver NeoplasmsUltrasoundGastroenterologyMagnetic resonance imagingHistologyGeneral MedicineultrasonographyMiddle AgedHepatologymedicine.diseaseImage EnhancementHemangioma; ultrasonography; Image Enhancement; Liver Cirrhosis; Liver Neoplasms; MicrobubblesLiver NeoplasmLiver HemangiomaMicrobubblesFemaleRadiologymedicine.symptombusinessNuclear medicineHemangioma
researchProduct

Normal and abnormal pulmonary ventilation: visualization at hyperpolarized He-3 MR imaging.

1996

To assess the feasibility of helium-3 magnetic resonance (MR) imaging with a three-dimensional fast low-angle shot (FLASH) sequence, He-3 gas (volume, 300 mL; pressure, 3 x 10(5) Pa; polarized up to 45% by means of optimal pumping) was inhaled by five healthy volunteers and five patients with pulmonary diseases. All breath-hold examinations (22-42 seconds) were completed successfully. Normal ventilation was depicted with homogeneous high signal intensity, lesions were depicted as causing defects, and obstructive lung disease was depicted with severely inhomogeneous signal intensity.

AdultLung DiseasesBronchiHyperpolarized Helium 3Respiratory physiologyHeliumIsotopesAdministration InhalationmedicineHumansRadiology Nuclear Medicine and imagingLungmedicine.diagnostic_testbusiness.industryRespirationRespiratory diseaseMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingMr imagingObstructive lung diseaseTracheaHomogeneousBreathingNuclear medicinebusinessRadiology
researchProduct

Early Lung Function Abnormalities in Acromegaly.

2014

BACKGROUND: Acromegaly is an insidious disorder caused by a pituitary growth hormone (GH)-secreting adenoma resulting in high circulating levels of GH and insulin-like growth factor I (IGF-I). Respiratory disorders are common complications in acromegaly, and can severely impact on quality of life, eventually affecting mortality. OBJECTIVES: The present study aimed to explore structural and functional lung alterations of acromegalic subjects. METHODS: We enrolled 10 consecutive patients (M/F: 5/5) affected by acromegaly. In all patients, magnetic resonance imaging (MRI) revealed the presence of pituitary tumor. All patients underwent clinical, lung functional, biological, and radiological as…

AdultLung DiseasesMalePulmonary and Respiratory MedicinePathologymedicine.medical_specialtyTime FactorsAdenomaVital CapacitySettore MED/10 - Malattie Dell'Apparato RespiratorioGastroenterologyspirometry dyspnea acromegalySettore MED/13 - EndocrinologiaPredictive Value of TestsDLCOForced Expiratory VolumeDiffusing capacityInternal medicineAcromegalymedicineHumansLung volumesRespiratory systemLungAgedLungbusiness.industryPituitary tumorsMiddle Agedrespiratory systemmedicine.diseaseMagnetic Resonance Imagingrespiratory tract diseasesRadiographyEarly Diagnosismedicine.anatomical_structureCase-Control StudiesPulmonary Diffusing CapacityFemaleGrowth Hormone-Secreting Pituitary AdenomaLung Volume Measurementsbusiness
researchProduct